An update: the role of Nephrin inside and outside the kidney by unknown
SCIENCE CHINA 
Life Sciences 
© The Author(s) 2015. This article is published with open access at link.springer.com life.scichina.com   link.springer.com 
                  
*Corresponding author (email: cijiang.he@mssm.edu) 
• REVIEW • July 2015  Vol.58  No.7: 649–657 
 doi: 10.1007/s11427-015-4844-1 
An update: the role of Nephrin inside and outside the kidney 
LI XueZhu1 & HE John Cijiang2* 
1Department of Nephrology; Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China; 
2Department of Medicine/Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA 
Received December 23, 2014; accepted February 27, 2015; published online April 15, 2015 
 
Nephrin is a key molecule in podocytes to maintain normal slit diaphragm structure. Nephin interacts with many other podo-
cyte and slit diaphragm protein and also mediates important cell signaling pathways in podocytes. Loss of nephrin during the 
development leads to the congenital nephrotic syndrome in children. Reduction of nephrin expression is often observed in 
adult kidney diseases including diabetic nephropathy and HIV-associated nephropathy. The critical role of nephrin has been 
confirmed by different animal models with nephrin knockout and knockdown. Recent studies demonstrate that knockdown of 
nephrin expression in adult mice aggravates the progression of unilateral nephrectomy and Adriamycin-induced kidney disease. 
In addition to its critical role in maintaining normal glomerular filtration unit in the kidney, nephrin is also expressed in other 
organs. However, the exact role of nephrin in kidney and extra-renal organs has not been well characterized. Future studies are 
required to determine whether nephrin could be developed as a drug target to treat patients with kidney disease. 
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The filtration property of the kidney localizes to the glo-
merular capillary wall, which forms a specialized filter that 
allows the passage of small plasma molecules, including 
water and waste products, from the circulating blood into 
the primary urine for excretion. This filtration barrier con-
sists of three layers: the fenestrated endothelium, glomerular 
basement membrane (GBM) and podocytes. Podocytes en-
close the outer aspect of the glomerular capillary wall and is 
the final barrier to filtration. Cytoplasmic extensions of the 
podocytes, called foot processes (FP), interdigitate each 
other from adjacent podocytes. Specialized cell-cell junc-
tions between the FP, called slit diaphragms (SD), form a 
zipper-like structure that functions as a sieve to restrict the 
passage of large molecules. 
Nephrin, an integral transmembrane protein of the im-
munoglobulin superfamily, is the first protein identified in 
the SD in 1998 [1]. Nephrin has crucial functions both in 
controlling the podocyte SD structure and as a hub of sig-
naling pathways. Although many years’ research efforts 
have been made, we are still far from having a complete 
understanding of nephrin’s role in podocyte as well as in 
other cell types. In this paper, we will review research pro-
gress related to the role of nephrin both inside and outside 
of the kidney. 
1  Molecular structure of nephrin 
NPHS1, gene that code Nephrin, was first cloned in 1998 by 
Kestilä and colleagues [1]. NPHS1 is assigned to the long 
arm of chromosome 19, 19q13.1, with a telomere-to-   
centromere orientation [1,2]. The size of NPHS1 gene is 26 
kb and it contains totally 29 exons. Northern hybridization 
and in situ hybridization suggest that NPHS1 is mostly lo-
calized in the glomerulus but also found in the brain, pan-
creas, testis, heat, spleen and lymphoid tissues. 
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Nephrin is a transmembrane protein with 1,241 residues 
and a calculated molecular weight of 135 kD without post-
translational modifications [1]. Nephrin composes of an 
extracellular domain containing eight IgG-like modules and 
one fibronectin type III-like motif, a single transmembrane 
domain and a short intracellular domain containing nine 
tyrosines. The IgG-like domains are of type C2 which is 
typically found in proteins participating in cell-cell [35] 
and cell-matrix interactions [6]. Nephrin has two cysteine 
residues in each IgG-like domain, which can form disulfide 
bridges between Nephrin molecules or with other proteins 
[1,7], leading to either homophilic interaction of Nephrin 
molecules or heterophilic interactions of Nephrin with other 
SD proteins. 
In sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) analysis, Nephrin runs as a 185200 
kD protein doublet suggesting posttranslational modifica-
tions [8,9]. In the extracellular domain of Nephrin there are 
10 potential sites for N-glycosylation [1] and glycosylation 
of Nephrin is critical for its proper folding and localization 
in the plasma membrane [10].  
Several spliced variants of Nephrin have been identified 
in both rats and humans. Nephrin-α, MW 166 kD, lacks the 
nucleotides 31673286 of exon 24, which codes the trans-
membrane spanning domain, produces a truncated soluble 
form of Nephrin. The function of Nephrin-α is still un-
known [11,12]. 
2  Location of Nephrin in the glomerulus 
In kidney, Nephrin exists exclusively at the filtration areas 
of the podocyte foot processes in glomerulus [13]. Nephrin 
molecules were proposed to interact in the slit through ho-
mophilic and heterophilic interactions of Nephrin with itself 
and with Neph family proteins forming a porous substruc-
ture in the SD. Nephrin mRNA was first detected in the late 
S-shaped bodies during the kidney development. Nephrin 
mRNA also shows a typical splicing pattern apparently reg-
ulated differently in various disease entities [11]. Nephrin 
mRNA has a very unique regulation by natural antisense 
mRNA [14] and bidirectional regulation with a closely re-
lated molecule, filtrin [15].  
Nephrin is also expressed in pronephric glomerulus of 
zebrafish and medaka in which Nephrin needs to be inte-
grated to the membrane before the formation of the SD and 
moving to the proper site to form the SD [16]. Nephrin is 
absent in the slit diaphragms of birds. Birds have larger SD 
as compared with mammalian glomeruli [17], and the ge-
nome of birds does not contain a coding sequence for 
Nephrin [18]. Birds excrete nitrogen mainly in the form of 
uric acid, which is not completely soluble in water and re-
quires a certain amount of proteins to be maintained in a 
colloidal suspension in the urine. Due to the absence of 
Nephrin, proteins could pass the glomerular filtration barrier. 
This is an indirect evidence to support the importance of 
Nephrin in mammals. 
3  Regulation of Nephrin expression 
3.1  Interaction with the other SD proteins 
Loss of Nephrin does not affect podocyte viability, sug-
gesting that Nephrin can be compensated by other podocyte 
molecules during glomerular development [19]. Nephrin 
can interact with the cytoskeleton through several proteins, 
but the relationship between Nephrin and the other podocyte 
molecules has not been fully demonstrated. 
3.1.1  CD2 adaptor protein (CD2AP) 
CD2AP is an intracellular protein initially found in 
T-lymphocyte molecule CD2. In glomerulus, CD2AP is 
also located at the SD and it can interact with Nephrin via 
its C-terminal domain [20,21]. CD2AP is an adaptor protein 
that is also important for the maintenance of the SD. The 
N-terminal domain of CD2AP can bind to p85 and facilitate 
the Nephrin-induced AKT signaling [22], which protects 
podocytes from apoptosis. CD2AP enhanced the small 
ubiquitin-related modification of CIN85, which increase the 
binding of CIN85 to Nephrin [23], induces Nephrin ubiqui-
tination and endocytosis [24].CD2AP knockout (CD2AP) 
mice are born healthy but develop a rapid-onset nephrotic 
syndrome at three weeks of age and die of renal failure at 
six weeks [21,25]. Kidneys from CD2AP mice initially 
exhibit normal Nephrin localization, but with aging the FP 
become effaced [26] and deficiency of CD2AP leads to a 
loss of expression of the SD protein Nephrin in podocytes. 
3.1.2  Podocin 
Podocin has been shown to be expressed only in the podo-
cytes, and serve as a scaffolding protein in the SD complex. 
Podocin is an integral membrane protein with both N and 
C-terminal domains directed into cytosol. Podocin associ-
ates via its C-terminal domain with cytoplasmic part of 
Nephrin at the specialized lipid raft microdomains of the 
plasma membrane [27,28]. NPHS2, the gene that codes po-
docin, is mutated in autosomal recessive steroid-resistant 
nephrotic syndrome and has a similar phenotype of CNF. 
Podocin-deficient mice also develop proteinuria during ear- 
 
 
Figure 1 (color online)  Location of Nephrin in podocyte. 
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ly antenatal period, and die in the five weeks after birth. 
Electron microscopy showed fusion of foot processes and 
massive mesangial sclerosis with vastly reduced Nephrin 
expression [29]. Podocin can recruit Nephrin into lipid rafts, 
connect via its C-terminal domain with CD2AP and then 
activate mitogen-activated protein kinase cascades [22,28]. 
And knocking down podocin expression in a cultured po-
docyte cell line by mRNA interference decreased Nephrin 
expression by 70% and altered Nephrin localization from 
the membrane surface to the nuclear area [30].  
3.1.3  Neph proteins 
The Neph protein family comprises three members: Neph1, 
Neph2 and Neph3. They belong to the immunoglobulin 
superfamily and are composed of a short intracellular do-
main and an extracellular domain with five Ig-like motifs 
[31,32]. Neph1 is a protein with weak homology and struc-
tural similarity to Nephrin.Neph1 can form a heterophilic 
interaction with Nephrin, via cis- or trans-interactions at the 
podocyte intercellular junction. [33,34]. The dissociation of 
Neph1 from Nephrin induced proteinuria in FSGS [35]. The 
Neph1-Nephrin complex cooperate to induce actin filament 
nucleation and elongation in a tyrosine phosphorylation 
dependent fashion at the plasma membrane by recruiting the 
cytoskeletal adaptor protein Nck1/2 and other proteins of 
the actin polymerization complex [36,37]. The lack of 
Neph1 leads to prenatal lethality with proteinuria and po-
docyte foot processes effacement in Neph1 knockout mice 
[38]. Neph1 also interacts with other SD proteins like podo-
cin [39] and ZO-1 [40]. 
Neph2 can also form homodimers and interacts specifi-
cally with the extracellular domain of Nephrin both in vitro 
and in vivo. The extracellular domain of Neph2 is cleaved 
under physiological conditions [41]. Neph3 is a pleiotropic 
gene active during distinct stages of tissue differentiation 
and associates directly with the regulation of both glomeru-
lar and neural development [42].  
3.1.4  Zonula occludens-1 (ZO-1) 
ZO-1 is a tight junction protein in the cytoplasmic base of 
SD. In diabetes, ZO-1 expression decreases and redistrib-
utes from podocyte membrane to the cytoplasm [43]. The 
lack of Nephrin does not affect the expression of ZO-1 in 
mice. However, injection of antibodies against p51 antigen, 
an epitope of Nephrin molecule, induces nephrosis in rats 
and leads to progressive decline of ZO-1. It was recently 
shown that ZO-1 may serve as a cytoplasmic organizer by 
coupling the Nephrin-Neph1 complex to the actin cytoskel-
eton and recruiting appropriate signal transduction compo-
nents to the SD area [9,44,45]. 
3.1.5  Alpha-actin 4 (ACTN4) 
The alpha-actinin-4 is an actin-bundling protein [46], and 
ubiquitously expressed. Mutations in ACTN4 lead to an 
inheritable form of glomerulosclerosis [46]. In alpha-   
actinin-4 mutant mice, Nephrin mRNA and protein levels 
were significantly reduced [47]. In vitro, silencing of 
Nephrin, using RNAi, did not change the expression of al-
pha-actinin-4, but silencing of alpha-actinin-4 downregu-
lated Nephrin and upregulated podocin and CD2AP expres-
sion [48].  
3.2  Nephrin-mediated intracellular signaling pathways 
Besides the important role in scaffolding of SD, Nephrin 
also serves as a “signaling node” in the SD by transmitting 
extracellular domain from the SD to the intracellular actin 
cytoskeleton [27,49,50]. Nephrin has the nine tyrosine resi-
dues in the intracellular domain, some of which are phos-
phorylated after ligand binding [51] and could serve as 
docking sites for SH2 domain-containing kinase and adap-
tor proteins. 
3.2.1 PI3K/AKT pathway 
The phosphorylated Nephrin can bind to the p85 regulatory 
subunit of phosphoinositide 3-OH kinase (PI3K), allowing 
the catalytic subunit p110 to act on the phospholipids of 
inner leaflet of the cell membrane, then stimulating the ser-
ine–threonine kinase AKT, which controls cell growth, mi-
gration, and survival [22]. Bad is one of the downstream 
target proteins of AKT. Bad interacts with pro-survival Bcl2 
family members to promote apoptosis. Phosphorylation of 
Bad protects podocytes against detachment-induced podo-
cyte apoptosis [22]. 
3.2.2  Nck 
Nephrin can bind to the Nck adaptor proteins after the 
phosphorylation by the Src-family tyrosine kinase Fyn. 
Nephrin-Nck interaction regulates FP morphology and actin 
dynamics and is important for podocyte FP development 
and repair after injury. Nck proteins contain one SH2 and 
three SH3 domains. The SH2 domain of Nck binds to 
phosphotyrosine residues of Nephrin, and the SH3 domain 
recruits other proteins involved in actin cytoskeleton regula-
tion. Recently it has been shown that inducible deletion of 
Nck1 and 2 in the podocytes of adult mice results in pro-
teinuria and reduces phosphorylation of Nephrin [36,52].  
3.2.3  PKC 
PKCα is a Nephrin binding protein, and sequence analysis 
of the Nephrin intracellular domain predicted a PKC recog-
nition motif. In diabetic nephropathy, Nephrin internaliza-
tion is accelerated through regulation of the β-arrestin2- 
Nephrin interaction by PKCα. PKCα can induce the binding 
of phosphorylated threonine residues 1120 and 1125 of 
Nephrin with β-arrestin2 [53,54]. Recently, Satoh and col-
leagues [55] have shown that the turnover rates of Nephrin 
was up-regulated by atypical protein kinase C (aPKC).  
3.2.4  Calcium signalling 
Nephrin plays a crucial role in the regulation of podocyte  
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Figure 2  Nephrin-mediated intracellular signaling pathways. 
calcium homeostasis. Phosphorylation of Nephrin at Tyr- 
1204 can recruit and activate phospholipase C-γ 1 (PLC-γ1), 
and then triggers a rapid [Ca2+]i influx in podocyte [56].  
3.2.5  Others 
Roundabout (Robo) family proteins are cell surface recep-
tors. Recently Robo2 has been shown to be expressed at the 
basal surface of podocytes and co-localizes with Nephrin 
and podocin. Robo2 signaling acts as a negative regulator 
on Nephrin signaling. Robo2 interacts directly with adaptor 
protein Nck and forms a complex with Nephrin, thereby 
inhibiting actin polymerization induced by Nephrin [57].  
4  Clinic features of Nephrin deficiency 
4.1  Nephrin in congenital nephrotic syndrome of Finn-
ish type 
Mutations in the NPHS1 gene cause congenital nephrotic 
syndrome of the Finnish type (CNF). The nephrotic syn-
drome progresses rapidly after birth and patients die within 
the first two years of life. CNF has an incidence of 1:10,000 
births in Finland, and an autosomal recessive mode of in-
heritance. Two mutations, named Finmajor and Finminor, were 
found in over 90% of CNF patients. The Finmajor is a dele-
tion (CT) in exon 2, which causes a frameshift and the for-
mation of stop codon at the end of exon 2. This mutation 
leads to a complete lack of Nephrin protein. Finminor is a 
nonsense mutation(C→T) in exon 26, leading to a truncated 
nephrin protein with 1109-residues [1,2]. 
The most classic clinic manifestation of CNF is heavy 
proteinuria, which begins in utero, along with hypopro-
teinemia and edema. The other abnormal findings include 
prematurity and large placenta. The clinical features of pa-
tients with Finmajor and Finminor mutations are similar. Thera-
pies with agents to reduce the glomerular filtration pressure 
have not been successful in reducing the proteinuria. Chil-
dren with CNF are currently treated with bilateral nephrec-
tomy and dialysis, followed by renal transplantation [58,59]. 
Under light microscopy, the kidney from patients with 
CNF is characterized by marked hyperplasia of mesangial 
cells, hyperlobulated capillary tufts, microcystic dilation of 
both proximal and distal tubuli, interstitial fibrosis and in-
flammation [45,60]. Diffuse podocyte foot process efface-
ment, narrowing of the filtration slits and absence of 
slit-diaphragms are observed on electron microscopy, indi-
cating that Nephrin is essential for the development of the 
SDs. 
Recurrence of CNF occurs in 20%25% of the patients 
after renal transplantation [61,62]. The recurrence of NS in 
CNF children appears only in patients with a Finmajor/Finmajor 
homozygous genotype and in patients with high levels of 
serum anti-Nephrin antibodies, suggesting an autoimmune 
reaction against Nephrin. 
4.2  Nephrin expression in acquired kidney diseases 
Nephrin expression has been shown to be down-regulated in 
many human glomerular disease and animal models [63]. In 
addition, it has been noted in several human biopsy and 
animal studies that Nephrin is localized away from the slit 
diaphragm and changes from a linear capillary loop pattern 
to a granular cytoplasmic pattern in nephrotic disease. 
4.2.1  Primary nephrotic syndrome 
Furness et al. compared the expression of Nephrin in human 
samples of six normal kidneys and four specimens of ne-
phrotic syndrome and found that Nephrin mRNA decreased 
in adult minimal change patients with nephrotic syndrome 
[64,65]. Nephrin staining is negative in sclerotic lesions in 
FSGS glomeruli, and in MN glomeruli with mesangial ex-
pansion. The expression of Nephrin was decreased only in 
the areas where the foot processes were effaced [66]. In the 
rat model of puromycin nephrosis, the glomerular Nephrin 
mRNA expression was diminished by 30% and 50% at days 
3 and 8 after puromycin injection [8,67]. Nephrin expres-
sion was also reduced in the kidney of passive Heymann 
nephritis rats model [68], and in a PAN rat model [65,69].  
Nephrin expression in podocyte is correlated inversely 
with extent of glomerulosclerosis, but not with the amount 
of proteinuria. Urinary neph/AQP is increased in adult ne-
phrotic syndrome (NS) patients, with the highest levels in 
FSGS patients [70]. 
However, some studies reported that expression of 
Nephrin did not change in proteinuric kidney disease 
[65,71]. Patrakka et al. [71] found that Nephrin mRNA and 
protein levels were similar between pediatric MCN patients 
and controls. Expression of Nephrin did not change in chil-
dren proteinuric kidney disease such as MCN, FSGS, and 
MN. These studies suggest that the reduction of nephrin is 
not necessarily the underlying mechanism of proteinuria in 
these diseases. 
4.2.2  Nephrin expression in diabetic nephropathy 
Aaltonen et al. [72] showed that glomerular Nephrin ex-
pression was increased by 50% in the STZ rats 4 weeks 
after induction of diabetes. Nephrin was found in the urine 
of the STZ-rats 4 to 6 weeks after induction of diabetes. 
However, in advanced DN, Nephrin expression seems to be 
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reduced. Bonnet et al. [73] showed that induction of diabe-
tes in spontaneously hypertensive rats by injection of STZ 
caused advanced DN together with significant reduction in 
glomerular Nephrin mRNA and protein levels. In human 
DN, Nephrin mRNA was reduced in renal biopsy samples 
of T2DM patients compared to healthy controls by 62% 
[74,75]. Also a reduction in Nephrin protein levels has been 
reported in diabetic patients with microalbuminuria and 
nephrotic syndrome [76].  
Nephrin expression is a marker of normal podocyte and 
the loss of podocytes correlating closely with disease pro-
gression [77]. It remains unclear whether reduction of 
nephrin in DN is second to loss of podocyte number or re-
duction of nephrin expression per podocyte. 
4.2.3  Other systemic and metabolic diseases 
Nephrin expression was absent in the sclerotic lesions and 
glomerular crescents of kidneys from patients with 
Henoch-Schonlein nephritis, lupus nephritis and some 
membranoproliferative glomerulonephritis. In lupus nephri-
tis (LN), the reduction of Nephrin expression started from 
the early stage in the kidney of NZB/W LN mice. In pa-
tients with LN, nephrin was decreased particularly in dif-
fuse proliferative LN and Nephrin expression correlates 
with disease severity in histology [78]. The levels of urinary 
nephrin excretion were increased in rheumatoid arthritis 
(RA) patients with nephropathie, and had a positive correla-
tion with urinary protein concentrations [79]. 
5  Nephrin deficient animal model for study 
5.1  Nephrin knock-out (KO) mice model 
Nephrin KO mice were born at an expected Mendelian ratio, 
and seemingly normal at birth. But consistent with the hu-
man CNF disease phenotype, Nephrin homozygous KO 
mice develop edema and heavy non-selective proteinuria 
immediately after births, and die within 24 h. The kidneys 
of the KO mice lacked Nephrin expression at both protein 
and mRNA levels. Similar to those in the glomeruli of CNF 
patients, these mice develop enlarged Bowman’s spaces, 
dilated tubules, and effacement of podocyte foot process 
with the absence of SD. The glomerular ultrastructure of the 
heterozygotes Nephrin KO mice was identical to normal 
wild-type mice, indicating that one functional allele is 
enough to maintain the normal structure and function of 
podocyte SD [13].  
In addition, podocyte-specific, doxycycline-induced 
transgenic expression of rat Nephrin in Nephrin KO mice 
successfully rescued the phenotype from perinatal death to 
normal morphology of podocytes and architecture of the SD 
[80]. Furthermore, KO of Nephrin in mice do not signifi-
cantly affect the glomerular morphogenesis, podocyte via-
bility or expression of other FPs and SD protein complex 
genes during development [19]. These data suggest that 
nephrin is critical for maintaining normal SD structure and 
prevent proteinuria. However, nephrin is not required for 
podocyte viability. 
5.2  Nephrin TRAP mice 
Rantanen and their colleagues generated a mutant Nphs1 
mouse line by gene-trapping. Nephrintrap/trap mutants show 
typical features of proteinuric disease and die soon after 
birth. Fibrotic glomeruli with distorted structures and cystic 
tubular lesions were found in the kidney. CD2AP and ZO-1 
appeared unchanged as compared with the wild-type (wt) 
and Nephrinwt/trap. Electron microscopy revealed that >90% 
of the podocyte foot processes were fused and slit dia-
phragms were missing. In Nephrinwt/trap, approximately 1/3 
of the FP were fused and Nephrin mRNA level decrease 
more than 60% [81].  
5.3  Anti-Nephrin antibody causes proteinuria in rats 
Injection of anti-Nephrin antibody (monoclonal antibody 
5-1-6) in rats results in immediate proteinuria and foot pro-
cess effacement. This antibody was recently shown to rec-
ognize an epitope of the extracellular domain of Nephrin [9]. 
The complement activation and leukocyte recruitment are 
absent in these rats. The glomerular histology remains intact 
except for partial retraction of the podocyte foot processes. 
The immediacy of proteinuria with relatively normal glo-
merular morphology in this rat model suggests that pro-
teinuria is likely caused by binding of the antibody to the 
extracellular domain of Nephrin, thereby disrupting the 
molecular rearrangement of the slit diaphragm and perm-
selectivity of the glomerular filtration barrier. The binding 
of this antibody can induce ligand endocytosis resulting in a 
loss of function or alteration of intracellular signaling medi-
ated by Nephrin. The exact mechanism through which an-
ti-Nephrin antibodies cause proteinuria in the mAb 5-1-6 
nephropathy model remains to be determined [82].  
5.4  siRNA-mediated inducible depletion of Nephrin 
model 
Early perinatal lethality of conventional Nephrin KO mice 
makes it impossible to study the role of Nephrin in the adult 
kidney. We generated transgenic mice with doxycy-
cline-inducible shRNA-mediated Nphs1 knockdown using 
an in vivo RNA interference approach in our laboratory 
[83] . Our in vivo studies demonstrate that short-term 
Nephrin knockdown (6 weeks), starting after the completion 
of kidney development, had no impact on glomerular struc-
ture and function. In contrast, mice with chronic Nephrin 
knockdown (20 weeks) developed mild proteinuria, foot 
process effacement, filtration slit narrowing, mesangial hy-
percellularity and sclerosis, glomerular basement membrane 
thickening, subendothelial zone widening, and podocyte 
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Table 1  Different Nephrin knock-out or knock-down animal model 
Animal model Species Generation method Phenotype 
Coventional Nephrin KO Mice Homologous recombination 
Homozygous mice: massive proteinuria, nephrotic syndrome, 
death soon after birth 
Heterozygous mice have no phenotype 
Mutant Nphs1 mice Gene-trap 
Nephrintrap/trap mutants show characteristic features of protein-
uric disease and die soon after birth. 
Nephrinwt/trap mice have no phenotype 
Anti-Nephrin antibody rat 
Inject anti-Nephrin monoclonal antibody mAb 
5-1-6 
Immediate proteinuria and foot process effacement 
siRNA-mediated Nephrin 
knockdown 
mice siRNA interference approach 
Chronic long-time Nephrin knockdown results in mild pro-
teinuria, foot process effacement in adulthood 
 
apoptosis.  
When subjected to an acquired glomerular insult induced 
by either unilateral nephrectomy or Adriamycin, mice with 
short-term Nephrin knockdown developed more severe 
glomerular injury compared to those without Nephrin 
knockdown. AKT phosphorylation was markedly reduced 
in mice with chronic Nephrin knockdown. Our data provide 
the first direct experimental evidence suggesting that under 
the basal condition and in acquired glomerular diseases, 
Nephrin is required to maintain slit diaphragm integrity and 
slit diaphragm-mediated signaling to preserve glomerular 
function in adult mice. 
6  Nephrin expression in extra-renal organs 
Expression of Nephrin is not limited to the podocyte in 
kidney. Nephrin expression is also found in the testis, cen-
tral nervous system (CNS), pancreas, placenta, heart and 
lymphoid tissue, indicating that Nephrin may have distinct 
functions in different tissues. 
6.1  CNS 
Nephrin is expressed in the fourth ventricle, spinal cord, 
cerebellum, hippocampus and olfactory bulb in the mouse 
brain during the development [13]. Recently, endogenous 
nephrin in adult rodent CNS had been found on the pons 
and corpus callosum and is expressed by granule cells and 
Purkinje cells of the cerebellum. In vitro study showed that 
nephrin expressed close to synaptic proteins and demon-
strate that nephrin interacts with Fyn kinase, glutamate re-
ceptors and the scaffolding molecule PSD95 [84]. However, 
histological analysis did not reveal any apparent morpho-
logical changes in the cerebellum of newborn Nephrin KO 
mice. The role of Nephrin in brain remains unclear. It has 
been reported that nearly10% of CNF patients have minor 
neurological abnormalities such as muscular dystonia, atax-
ia and athetosis. However, these abnormalities may also be 
a complication of the severe proteinuria or other co-     
morbidities. 
6.2  Pancreas 
In the pancreas, Nephrin expression is localized to the insu-
lin-producing cells of the islets of Langerhans [13,85], beta 
cells [85] and islet microendothelia [86]. Although the exact 
function of Nephrin in pancreas is still unknown, it may 
serve as a structural protein in islet microendothelium [86]. 
Glucose levels and insulin secretion are normal in CNF pa-
tients as assessed by OGTT test [87]. 
6.3  Testis 
Nephrin is also expressed in Sertoli cells of the mouse testis 
[88]. Sertoli cells provide mechanical support, protection 
and nutrition to the developing germ cells, and formation of 
the blood-testis barrier. Nephrin seems to have an important 
role in these functions. Nephrin KO male mice were infer-
tile, with undescended testicles and impaired seminal vesi-
cle formation. Abnormal pubertal development and testicu-
lar function have also been reported in male CNF patients 
[87] . 
6.4  Lymphoid tissue 
Nephrin can be found in the spleen of the rat [8]. Aström et 
al. [89] demonstrated Nephrin expression in human tonsil, 
adenoid and lymph node. Nephrin-positive cells were de- 
tected in the germinal centers of the lymphoid follicles in a 
staining pattern typical for dentritic cells. Dendritic cells 
maintain the framework in the lymphoid follicle and offer a 
stable network for proliferation and differentiation of B 
lymphocytes [90]. Therefore, Nephrin may act as a cell 
junction adhesion molecule in lymphoid tissue, similarly to 
its function in the SD. 
6.5  Heart 
Nephrin is also required for cardiovascular development. 
Nephrin is expressed in the epicardium and coronary vessels 
during human and mouse embryonic development. Nephrin 
KO showed abnormal epicardial cell morphology and a re-
duced number of coronary vessels, and cardiac fibrosis [91]. 
7  Conclusion 
Taken together, Nephrin is a key scaffolding protein in po- 
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Figure 3  Nephrin in different organs. 
docyte SD. Nephrin is required for maintaining SD integrity 
and SD-mediated signaling to preserve glomerular function 
and podocyte viability. Reduced expression or abnormal 
distribution of Nephrin has been observed in many glomer-
ular diseases. Future studies are required to confirm whether 
Nephrin expression could be used as a biomarker for pre-
diction of the progression of glomerular disease or Nephrin 
could be developed as a potential drug target for treatment 
of glomerular disease. In addition, it would be interesting to 
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